Amgen Inc. is a large biopharmaceutical company that researches, develops, and sells medicines. It lobbies Congress on drug pricing and Medicare/Medicaid rules, funding and reimbursement for biologic drugs, FDA regulation, patient affordability tools like copay assistance, and tax issues including corporate and international tax rules. Recent filings also show interest in patent and tariff matters.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
CHAD PETTIT
The latest disclosures for this client.
AMGEN, INC.
Q2AMGEN, INC.
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
These contribution items line up to this client through the same lobbying firm and reporting window, and when available the same contributing lobbyist.
AMGEN, INC.
CHASE THOMAS
AMGEN, INC.
GREGORY PORTNER
AMGEN, INC.
HELEN RHEE
AMGEN, INC.
HOWARD MOON
AMGEN, INC.
JESSE KERNS
AMGEN, INC.
L NICOLE CURRIE
AMGEN, INC.
mr MATTHEW MCMURRAY
AMGEN, INC.
AMGEN, INC.
Q4AMGEN, INC.
2AAMGEN, INC.
Q3AMGEN, INC.
Q2AMGEN, INC.
Q1